Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Erratum for Rajam et al., "Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States".

Rajam G, Stella M, Kim E, Paulos S, Boccadifuoco G, Serino L, Carlone G, Medini D.

mSphere. 2019 Jun 12;4(3). pii: e00253-19. doi: 10.1128/mSphere.00253-19. No abstract available.

2.

Late effects of total body irradiation on hematopoietic recovery and immune function in rhesus macaques.

Hale LP, Rajam G, Carlone GM, Jiang C, Owzar K, Dugan G, Caudell D, Chao N, Cline JM, Register TC, Sempowski GD.

PLoS One. 2019 Feb 13;14(2):e0210663. doi: 10.1371/journal.pone.0210663. eCollection 2019.

3.

Streptococcus infantis, Streptococcus mitis, and Streptococcus oralis Strains With Highly Similar cps5 Loci and Antigenic Relatedness to Serotype 5 Pneumococci.

Pimenta F, Gertz RE Jr, Park SH, Kim E, Moura I, Milucky J, Rouphael N, Farley MM, Harrison LH, Bennett NM, Bigogo G, Feikin DR, Breiman R, Lessa FC, Whitney CG, Rajam G, Schiffer J, da Gloria Carvalho M, Beall B.

Front Microbiol. 2019 Jan 8;9:3199. doi: 10.3389/fmicb.2018.03199. eCollection 2018.

4.

Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.

Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, Comanducci M, Lemos AP, Gorla MC, Křížová P, Mikula C, Mulhall R, Nissen M, Nohynek H, Simões MJ, Skoczyńska A, Stefanelli P, Taha MK, Toropainen M, Tzanakaki G, Vadivelu-Pechai K, Watson P, Vazquez JA, Rajam G, Rappuoli R, Borrow R, Medini D.

Vaccine. 2019 Feb 8;37(7):991-1000. doi: 10.1016/j.vaccine.2018.12.061. Epub 2019 Jan 17.

5.

Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule.

Lessa FC, Milucky J, Rouphael NG, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Gertz RE, Rajam G, Carvalho MDG, Beall B, Whitney CG.

Sci Rep. 2018 Dec 19;8(1):17959. doi: 10.1038/s41598-018-35921-3.

6.

Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.

Rajam G, Carlone G, Kim E, Choi J, Paulos S, Park S, Jeyachandran A, Gorantla Y, Wong E, Sabnis A, Browning P, Desai R, Quinn CP, Schiffer J.

Biologicals. 2019 Jan;57:9-20. doi: 10.1016/j.biologicals.2018.11.001. Epub 2018 Nov 18.

PMID:
30458978
7.

Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting.

Ibrahim R, Ali SA, Kazi AM, Rizvi A, Guterman LB, Bednarczyk RA, Kim E, Park S, Paulos S, Jeyachandran A, Patel D, Gorantla Y, Wong E, Rajam G, Schiffer J, Omer SB.

Vaccine. 2018 Nov 12;36(46):7048-7053. doi: 10.1016/j.vaccine.2018.09.045. Epub 2018 Oct 5.

8.

Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States.

Rajam G, Stella M, Kim E, Paulos S, Boccadifuoco G, Serino L, Carlone G, Medini D.

mSphere. 2017 Nov 15;2(6). pii: e00261-17. doi: 10.1128/mSphere.00261-17. eCollection 2017 Nov-Dec. Erratum in: mSphere. 2019 Jun 12;4(3):.

9.

Augmented Passive Immunotherapy with P4 Peptide Improves Phagocyte Activity in Severe Sepsis.

Morton B, Mitsi E, Pennington SH, Reiné J, Wright AD, Parker R, Welters ID, Blakey JD, Rajam G, Ades EW, Ferreira DM, Wang D, Kadioglu A, Gordon SB.

Shock. 2016 Dec;46(6):635-641.

PMID:
27488089
10.

Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.

Broderick MP, Romero-Steiner S, Rajam G, Johnson SE, Milton A, Kim E, Choi LJ, Radin JM, Schmidt DS, Carlone GM, Messonnier N, Faix DJ.

Clin Vaccine Immunol. 2016 Aug 5;23(8):672-80. doi: 10.1128/CVI.00267-16. Print 2016 Aug.

11.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B.

Nat Immunol. 2014 Feb;15(2):195-204. doi: 10.1038/ni.2789. Epub 2013 Dec 15.

12.

Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.

Bangert M, Wright AK, Rylance J, Kelly MJ, Wright AD, Carlone GM, Sampson JS, Rajam G, Ades EW, Kadioglu A, Gordon SB.

Antimicrob Agents Chemother. 2013 Sep;57(9):4566-9. doi: 10.1128/AAC.00742-13. Epub 2013 Jul 1.

13.

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Plikaytis BD, Stella M, Boccadifuoco G, DeTora LM, Agnusdei M, Santini L, Brunelli B, Orlandi L, Simmini I, Giuliani M, Ledroit M, Hong E, Taha MK, Ellie K, Rajam G, Carlone GM, Claus H, Vogel U, Borrow R, Findlow J, Gilchrist S, Stefanelli P, Fazio C, Carannante A, Oksnes J, Fritzsønn E, Klem AM, Caugant DA, Abad R, Vázquez JA, Rappuoli R, Pizza M, Donnelly JJ, Medini D.

Clin Vaccine Immunol. 2012 Oct;19(10):1609-17. Epub 2012 Aug 8.

14.

P4-mediated antibody therapy in an acute model of invasive pneumococcal disease.

Bangert M, Bricio-Moreno L, Gore S, Rajam G, Ades EW, Gordon SB, Kadioglu A.

J Infect Dis. 2012 May 1;205(9):1399-407. doi: 10.1093/infdis/jis223. Epub 2012 Mar 29.

PMID:
22457294
15.

A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia.

Rajam G, Hammons GM, Carlone GM, Sampson JS, Ades EW.

Int J Microbiol. 2011;2011:725483. doi: 10.1155/2011/725483. Epub 2011 Nov 16.

16.

Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.

Weeks JN, Boyd KL, Rajam G, Ades EW, McCullers JA.

Antimicrob Agents Chemother. 2011 May;55(5):2276-81. doi: 10.1128/AAC.00057-11. Epub 2011 Mar 7.

17.

P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.

Rajam G, Bangert M, Hammons GM, Melnick N, Carlone GM, Sampson JS, Ades EW.

Clin Vaccine Immunol. 2010 Nov;17(11):1823-4. doi: 10.1128/CVI.00366-10. Epub 2010 Sep 15. No abstract available.

18.

An augmented passive immune therapy to treat fulminant bacterial infections.

Rajam G, Sampson J, Carlone GM, Ades EW.

Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):157-67. Review.

PMID:
20370679
19.

Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.

Whaley MJ, Sampson JS, Johnson SE, Rajam G, Stinson-Parks A, Holder P, Mauro E, Romero-Steiner S, Carlone GM, Ades EW.

Vaccine. 2010 Apr 19;28(18):3071-5. doi: 10.1016/j.vaccine.2010.02.086. Epub 2010 Mar 4.

PMID:
20206671
20.

Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.

Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.

J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131.

PMID:
20088694
21.

Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.

Melnick N, Rajam G, Carlone GM, Sampson JS, Ades EW.

Clin Vaccine Immunol. 2009 Jun;16(6):806-10. doi: 10.1128/CVI.00120-09. Epub 2009 Apr 22. Erratum in: Clin Vaccine Immunol. 2009 Jul;16(7):1093.

22.

A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection.

Rajam G, Skinner J, Melnick N, Martinez J, Carlone GM, Sampson JS, Ades EW.

J Infect Dis. 2009 Apr 15;199(8):1233-8. doi: 10.1086/597425.

PMID:
19265478
23.

Pneumococcal surface adhesin A (PsaA): a review.

Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW.

Crit Rev Microbiol. 2008;34(3-4):163-73. doi: 10.1080/10408410802383610. Retraction in: Crit Rev Microbiol. 2009 Feb;35(1):67.

PMID:
18819028
24.

Pneumococcal surface adhesin A (PsaA): a review.

Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW.

Crit Rev Microbiol. 2008;34(3-4):131-42. doi: 10.1080/10408410802275352 . Review.

PMID:
18728990
25.

A functional epitope of the pneumococcal surface adhesin A activates nasopharyngeal cells and increases bacterial internalization.

Rajam G, Phillips DJ, White E, Anderton J, Hooper CW, Sampson JS, Carlone GM, Ades EW, Romero-Steiner S.

Microb Pathog. 2008 Mar;44(3):186-96. Epub 2007 Oct 5.

PMID:
17997274
26.

Functional antibodies to the O-acetylated pneumococcal serotype 15B capsular polysaccharide have low cross-reactivities with serotype 15C.

Rajam G, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2007 Sep;14(9):1223-7. Epub 2007 Jul 3.

27.

An in vitro model to assess pneumococcal adherence to nasopharyngeal cells under competition conditions.

Rajam G, Jackson D, Pilishvili T, Whitney CG, Facklam RR, Carlone GM, Romero-Steiner S.

J Microbiol Methods. 2007 Aug;70(2):219-26. Epub 2007 Apr 24.

PMID:
17512994
28.

E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of Streptococcus pneumoniae.

Anderton JM, Rajam G, Romero-Steiner S, Summer S, Kowalczyk AP, Carlone GM, Sampson JS, Ades EW.

Microb Pathog. 2007 May-Jun;42(5-6):225-36. Epub 2007 Feb 27.

PMID:
17412553
29.

Adherence of recombinant pneumococcal surface adhesin A (rPsaA)-coated particles to human nasopharyngeal epithelial cells for the evaluation of anti-PsaA functional antibodies.

Romero-Steiner S, Caba J, Rajam G, Langley T, Floyd A, Johnson SE, Sampson JS, Carlone GM, Ades E.

Vaccine. 2006 Apr 12;24(16):3224-31. Epub 2006 Feb 2.

PMID:
16487631
30.

Fluorescent multivalent opsonophagocytic assay for measurement of functional antibodies to Streptococcus pneumoniae.

Bieging KT, Rajam G, Holder P, Udoff R, Carlone GM, Romero-Steiner S.

Clin Diagn Lab Immunol. 2005 Oct;12(10):1238-42.

Supplemental Content

Support Center